As of today (2024-04-24), Accuray's share price is $2.215.
Accuray's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.08. Hence, Accuray's Price-to-Free-Cash-Flow Ratio for today is 28.40.
The historical rank and industry rank for Accuray's Price-to-Free-Cash-Flow or its related term are showing as below:
ARAY'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.03 Med: 33.97 Max: 182.61
Current: 28.56
During the past 13 years, Accuray's highest Price-to-Free-Cash-Flow Ratio was 182.61. The lowest was 7.03. And the median was 33.97.
ARAY's Price-to-Free-Cash-Flow is ranked better than 53.55% of 338
companies
in the Medical Devices & Instruments industry
Industry Median: 31.755
vs ARAY: 28.56
During the past 13 years, Accuray's highest 3-Year average Free Cash Flow per Share Growth Rate was 41.70% per year. The lowest was -87.10% per year. And the median was 22.80% per year.
Accuray Price-to-Free-Cash-Flow Historical Data
The historical data trend for Accuray's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Accuray's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accuray Price-to-Free-Cash-Flow Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Accuray's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Accuray's Price-to-Free-Cash-Flow falls into.
Accuray Price-to-Free-Cash-Flow Calculation
Accuray's Price-to-Free-Cash-Flow ratio for today is calculated as
Accuray's Share Price of today is $2.215.
Accuray's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Accuray Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Accuray's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARAY has been successfully added to your 